Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126680262 | 12668026 | 2 | F | 20160902 | 20160819 | 20160907 | EXP | US-ELI_LILLY_AND_COMPANY-US201608007107 | ELI LILLY AND CO | 0.00 | F | Y | 0.00000 | 20160907 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126680262 | 12668026 | 1 | PS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 20 MG, QD | 21427 | 20 | MG | CAPSULE | QD | ||||||
| 126680262 | 12668026 | 2 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 40 MG, QD | 21427 | 40 | MG | CAPSULE | QD | ||||||
| 126680262 | 12668026 | 3 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 60 MG, QD | 21427 | 60 | MG | CAPSULE | QD | ||||||
| 126680262 | 12668026 | 4 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 40 MG, QD | 21427 | 40 | MG | CAPSULE | QD | ||||||
| 126680262 | 12668026 | 5 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 20 MG, QD | 21427 | 20 | MG | CAPSULE | QD | ||||||
| 126680262 | 12668026 | 6 | SS | DULOXETINE HYDROCHLORIDE. | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 20 MG, QD | U | U | 0 | 20 | MG | CAPSULE | QD | ||||
| 126680262 | 12668026 | 7 | SS | DULOXETINE HYDROCHLORIDE. | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 20 MG, QOD | U | U | 0 | 20 | MG | CAPSULE | QOD | ||||
| 126680262 | 12668026 | 8 | SS | DULOXETINE HYDROCHLORIDE. | DULOXETINE HYDROCHLORIDE | 1 | U | U | 0 | CAPSULE | |||||||||
| 126680262 | 12668026 | 9 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | UNK, UNKNOWN | 0 | ||||||||||
| 126680262 | 12668026 | 10 | C | TRILEPTAL | OXCARBAZEPINE | 1 | Unknown | UNK, UNKNOWN | 0 | ||||||||||
| 126680262 | 12668026 | 11 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | UNK, UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126680262 | 12668026 | 1 | Depression |
| 126680262 | 12668026 | 2 | Migraine |
| 126680262 | 12668026 | 6 | Depression |
| 126680262 | 12668026 | 7 | Migraine |
| 126680262 | 12668026 | 8 | Trigeminal neuralgia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126680262 | 12668026 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126680262 | 12668026 | Dizziness | |
| 126680262 | 12668026 | Nausea | |
| 126680262 | 12668026 | Trigeminal neuralgia | |
| 126680262 | 12668026 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126680262 | 12668026 | 3 | 2013 | 0 |